| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
|
Lancet
|
2009
|
13.64
|
|
2
|
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).
|
Nat Genet
|
2009
|
8.39
|
|
3
|
A common 8q24 variant in prostate and breast cancer from a large nested case-control study.
|
Cancer Res
|
2007
|
3.08
|
|
4
|
Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women.
|
Arterioscler Thromb Vasc Biol
|
2002
|
2.79
|
|
5
|
C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study).
|
Am J Cardiol
|
2004
|
2.08
|
|
6
|
Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events.
|
Circulation
|
2006
|
1.85
|
|
7
|
Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women.
|
Cancer Res
|
2007
|
1.82
|
|
8
|
Hemoglobin A1c level and future cardiovascular events among women.
|
Arch Intern Med
|
2004
|
1.76
|
|
9
|
IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
|
PLoS One
|
2008
|
1.50
|
|
10
|
Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study.
|
Lancet
|
2002
|
1.46
|
|
11
|
Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.23
|
|
12
|
Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium.
|
Hum Mol Genet
|
2010
|
1.16
|
|
13
|
PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).
|
Carcinogenesis
|
2009
|
1.13
|
|
14
|
A prospective study of androgen levels, hormone-related genes and risk of rheumatoid arthritis.
|
Arthritis Res Ther
|
2009
|
1.00
|
|
15
|
CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
1.00
|
|
16
|
Haplotypes of the estrogen receptor beta gene and breast cancer risk.
|
Int J Cancer
|
2008
|
0.99
|
|
17
|
MDM2 SNP309 is associated with endometrial cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
0.98
|
|
18
|
A polymorphism in the 3' untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 is not associated with an increase in breast cancer risk: a nested case-control study.
|
Breast Cancer Res
|
2007
|
0.98
|
|
19
|
The mitochondrial A10398G polymorphism, interaction with alcohol consumption, and breast cancer risk.
|
PLoS One
|
2009
|
0.97
|
|
20
|
A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
|
Breast Cancer Res
|
2006
|
0.97
|
|
21
|
Age-related cataract in a randomized trial of beta-carotene in women.
|
Ophthalmic Epidemiol
|
2004
|
0.96
|
|
22
|
Androgen receptor polymorphisms and endometrial cancer risk.
|
Int J Cancer
|
2006
|
0.94
|
|
23
|
Novel breast cancer risk alleles and endometrial cancer risk.
|
Int J Cancer
|
2008
|
0.93
|
|
24
|
Common genetic variation within IGFI, IGFII, IGFBP-1, and IGFBP-3 and endometrial cancer risk.
|
Gynecol Oncol
|
2011
|
0.92
|
|
25
|
Candidate genetic variants in the fibrinogen, methylenetetrahydrofolate reductase, and intercellular adhesion molecule-1 genes and plasma levels of fibrinogen, homocysteine, and intercellular adhesion molecule-1 among various race/ethnic groups: data from the Women's Genome Health Study.
|
Am Heart J
|
2009
|
0.85
|
|
26
|
Genetic variation in CYP11A1 and StAR in relation to endometrial cancer risk.
|
Gynecol Oncol
|
2010
|
0.84
|
|
27
|
Genetic variations in UGT1A1 and UGT2B7 and endometrial cancer risk.
|
Pharmacogenet Genomics
|
2009
|
0.84
|
|
28
|
Plasma carotenoid- and retinol-weighted multi-SNP scores and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.81
|
|
29
|
Polymorphisms in genes hydroxysteroid-dehydrogenase-17b type 2 and type 4 and endometrial cancer risk.
|
Gynecol Oncol
|
2010
|
0.80
|
|
30
|
Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
|
BMC Cancer
|
2009
|
0.78
|